Jiahui and colleagues reported that a DNAJC subfamily member, T-cell activation inhibitor in mitochondria (TCAIM), provides posttranslational modification and protection to -ketoglutarate dehydrogenase in an HSPA9-dependent manner (Jiahui et al., 2025), revealing a novel mode of mitochondrial chaperoning
S., Taichman, R
A formal Phase 2 trial was completed in 2009, but over 15 years later, the results have never been published, another major red flag suggesting it failed to prove effective or safe
Las cantidades habituales son 1 mg, 5 mg, 10 mg o 15 mg
Guidance Next to financing, we offer young entrepreneurs guidance & appropriate feedback which can help to move start-up ideas to the next level
In laboratory and neurological models, it is primarily studied for its influence on synaptic connectivity, neurotrophic pathways, and cognitive signaling mechanisms